Mediators of the effect of ertugliflozin on a composite kidney outcome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: analyses from VERTIS CV Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Cherney, D. Z. I.; Segar, M.; Pandey, A.; Cannon, C. P.; Cosentino, F.; Dagogo-Jack, S.; Pratley, R. E.; Frederich, R.; Cater, N. B.; Maldonado, M.; Liu, J.; Liu, C. -C.; Pong, A.; McGuire, D. K.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

start page

  • 2925

end page

  • 2925

volume

  • 42